BIAsp 30 (biphasic insulin aspart 30/70 biosimilar) / Novo Nordisk  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BIAsp 30 (biphasic insulin aspart 30/70 biosimilar) / Novo Nordisk
ChiCTR1800020301: Add long-acting insulin or premixed insulin after oral antidiabetic drugs failing to reach HbA1c target: a randomized, cross-over trial

Not yet recruiting
N/A
50
 
Glargine - Asp30 ;Asp30-IGlar
The Second Affiliated Hospital of Guangzhou Medical University; Level of the institution：, Guangzhou medical and health science and technology project (project number: 20171A11301)
Type 2 diabetes
 
 

Download Options